CD40 Recombinant Protein

Reference: PX-P4082-100
Size

100ug

Brand

Product type

Host Species

Applications

,

Product nameCD40 Recombinant Protein
Uniprot IDP25942
Uniprot linkhttp://www.uniprot.org/uniprot/P25942
Origin speciesHomo sapiens (Human)
Expression systemEukaryotic expression
SequenceMVRLPLQCVLWGCLLTAVHPEPPTACREKQYLINSQCCSLCQPGQKLVSDCTEFTETECLPCGESEFLDTWNRETHCHQHKYCDPNLGLRVQQKGTSETDTICTCEEGWHCTSEACESCVLHRSCSPGFGVKQIATGVSDTICEPCPVGFFSNVSSAFEKCHPWTSCETKDLVVQQAGTNKTDVVCGPQDRLR
Molecular weight22.32kDa
Protein delivered with Tag?C-terminal His Tag
Purity estimated>90% by SDS-PAGE
BufferPBS pH7.5
Delivery conditionDry Ice
Storage conditionStore at - 20? to -80?. It is recommended that the protein be aliquoted for optimal storage.
BrandProteoGenix
Host speciesMammalian cells
ApplicationsELISA,WB
Fragment TypeMet1~Arg193
Aliases /SynonymsTNFRSF5
ReferencePX-P4082
NoteFor research use only

General information on CD40 Recombinant Protein:

CD40, also known as TNFRSF5, is a member of the TNF receptor superfamily, which is a single transmembrane glycoprotein. The CD40 protein plays a vital role in mediating a variety of immune and inflammatory responses, including the change in class T that depends on the type of immunoglobulin, the development of B cell memory and the formation of reproductive centers. The CD40 protein is expressed in B cells, dendritic cells, macrophages, endothelial cells and some tumor cells. CD40 deficiency can lead to high IgM type 3 (HIGM3) immunodeficiency. In addition, ?-amyloid-induced microglia activation requires CD40 / CD40L interaction and is therefore considered an early event in the pathogenesis of Alzheimer’s disease.

Iscalimab Biosimilar - Anti-CD40, TNFRSF5 mAb binds to CD40 Recombinant Protein in indirect ELISA Assay

Immobilized CD40 Recombinant Protein (cat. No.PX-P4082) at 0.5µg/mL (100µL/well) can bind to Iscalimab Biosimilar - Anti-CD40, TNFRSF5 mAb (cat. No.PX-TA1503) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “CD40 Recombinant Protein”

Your email address will not be published. Required fields are marked *

Related products

Teneliximab Biosimilar – Anti-CD40, TNFRSF5 mAb – Research Grade
Biosimilar Teneliximab Biosimilar – Anti-CD40, TNFRSF5 mAb – Research Grade PX-TA1196 400€
Bleselumab Biosimilar – Anti-CD40,  TNFRSF5 mAb – Research Grade
Biosimilar Bleselumab Biosimilar – Anti-CD40, TNFRSF5 mAb – Research Grade PX-TA1393 400€
Selicrelumab Biosimilar – Anti-CD40, TNFRSF5 mAb – Research Grade
Biosimilar Selicrelumab Biosimilar – Anti-CD40, TNFRSF5 mAb – Research Grade PX-TA1465 400€
Iscalimab Biosimilar – Anti-CD40, TNFRSF5 mAb – Research Grade
Biosimilar Iscalimab Biosimilar – Anti-CD40, TNFRSF5 mAb – Research Grade PX-TA1503 400€
Mitazalimab Biosimilar – Anti-CD40, TNFRSF5 mAb – Research Grade
Biosimilar Mitazalimab Biosimilar – Anti-CD40, TNFRSF5 mAb – Research Grade PX-TA1515 400€
Vanalimab Biosimilar – Anti-CD40 mAb – Research Grade
Biosimilar Vanalimab Biosimilar – Anti-CD40 mAb – Research Grade PX-TA1735 400€
Tecaginlimab Biosimilar – Anti-CD40 & CD137 mAb – Research Grade
Biosimilar Tecaginlimab Biosimilar – Anti-CD40 & CD137 mAb – Research Grade PX-TA1777 400€
Cifurtilimab Biosimilar – Anti-CD40 mAb – Research Grade
Biosimilar Cifurtilimab Biosimilar – Anti-CD40 mAb – Research Grade PX-TA1825 400€
Frexalimab Biosimilar – Anti-CD40LG mAb – Research Grade
Biosimilar Frexalimab Biosimilar – Anti-CD40LG mAb – Research Grade PX-TA1842 400€
Giloralimab Biosimilar – Anti-CD40 mAb – Research Grade
Biosimilar Giloralimab Biosimilar – Anti-CD40 mAb – Research Grade PX-TA1845 400€
Inezetamab Biosimilar – Anti-CD40;MSLN mAb – Research Grade
Biosimilar Inezetamab Biosimilar – Anti-CD40;MSLN mAb – Research Grade PX-TA1849 400€
Toralizumab Biosimilar – Anti-sCD40L mAb – Research Grade
Biosimilar Toralizumab Biosimilar – Anti-sCD40L mAb – Research Grade PX-TA1925 400€
CD40 ligand(CD40LG)
Ligand CD40 ligand(CD40LG) PX-P4855 210€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.